United States· US:68982-261_5be10bd2-a785-7f3b-0d28-d066cd5f7d24
Balfaxar
A medicinal product containing coagulation factor ix human; prothrombin; coagulation factor vii human; coagulation factor x human; protein c; protein s human, registered in United States by Octapharma USA Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- COAGULATION FACTOR IX HUMAN; PROTHROMBIN; COAGULATION FACTOR VII HUMAN; COAGULATION FACTOR X HUMAN; PROTEIN C; PROTEIN S HUMAN
- Manufacturer
- Octapharma USA Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1168982-261-01
- ndc1168982-261-02
- ndc1168982261011 VIAL, GLASS in 1 CARTON (68982-261-01) / 20 mL in 1 VIAL, GLASS (68982-261-81)
- ndc1168982261021 VIAL, GLASS in 1 CARTON (68982-261-02) / 40 mL in 1 VIAL, GLASS (68982-261-82)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Coagulation factor ix human; prothrombin; coagulation factor vii human; coagulation factor x human; protein c; protein s human in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenConfidex 1000 IE Pulver och vätska till injektionsvätska, lösningCSL Behring GmbH
- NorwayConfidexCSL Behring GmbH (2)
- GermanyBeriplex P/NCsl Behring Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Beriplex P/N, Cofact
- Belgium · Cofact, Confidex
- Bulgaria · Octaplex, Бериплекс P/N
- Cyprus · Beriplex P/N, Octaplex
- Czechia · Beriplex, Ocplex
- Germany · Beriplex P/N, Cofact
- Denmark · Confidex, Octaplex
- Estonia · Octaplex
- Spain · Beriplex, Cofact
- Finland · Cofact, Confidex
- France · Cofact, Confidex
- United Kingdom (Northern Ireland) · Beriplex P/N, Octaplex
- Greece · Beriplex P/N
- Croatia · Beriplex P/N, Octaplex
- Hungary · Beriplex P/N, Octaplex
- Ireland · Beriplex P/N, Octaplex Coagulation Factor Ix
- Iceland · Cofact, Octaplex
- Italy · Cofact, Confidex
- Lithuania · Octaplex
- Luxembourg · Cofact, Confidex
- Latvia · Octaplex
- Malta · Beriplex P/N, Octaplex
- Netherlands · Beriplex P/N, Cofact
- Norway · Confidex, Octaplex
- Poland · Beriplex P/N, Octaplex
- Portugal · Beriplex, Octaplex
- Romania · Beriplex P/N, Pronativ
- Sweden · Confidex, Ocplex
- Slovenia · Beriplex P/N, Octaplex
- Slovakia · Beriplex, Octaplex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/66edfc00-161f-45d6-8365-1828f0fde5a9 GET /v1/drugs/66edfc00-161f-45d6-8365-1828f0fde5a9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "25.5; 26; 16.5; 24; 22; 22",
"substance": "COAGULATION FACTOR IX HUMAN; PROTHROMBIN; COAGULATION FACTOR VII HUMAN; COAGULATION FACTOR X HUMAN; PROTEIN C; PROTEIN S HUMAN",
"productndc": "68982-261",
"dosage_form": "POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "[iU]/mL; [iU]/mL; [iU]/mL; [iU]/mL; [iU]/mL; [iU]/mL",
"application_number": "BLA125776",
"marketing_category": "BLA"
}See everything about coagulation factor ix human; prothrombin; coagulation factor vii human; coagulation factor x human; protein c; protein s human.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.